Clinical trials in Ossy

Clinical trials focusing on hidradenitis suppurativa (HS), investigating the long-term effectiveness and safety of novel therapeutic approaches. Research includes evaluating treatment responses in patients with moderate to severe conditions.

• Spesolimab Studies
• Long-term Safety Assessments
• Treatment Optimization

Multiple phases of research aim to determine optimal dosing strategies and confirm treatment efficacy.

Comprehensive research into moderate-to-severe atopic dermatitis treatments, including studies of oral medications and innovative biological therapies. These trials aim to expand treatment options for patients.

• BP1.7881 Clinical Evaluation
• Lebrikizumab Studies
• Long-term Safety Monitoring

Extended observation periods of up to 2 years ensure thorough assessment of treatment outcomes.

Advanced clinical research exploring novel treatment approaches for chronic skin conditions. Studies incorporate both adult and adolescent patient populations to ensure comprehensive therapeutic development.

• Drug Safety Profiles
• Treatment Efficacy
• Patient Response Monitoring

Research protocols include randomized, double-blind, placebo-controlled methodologies to ensure robust results.